BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9031819)

  • 1. Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice.
    Bernstein MA; Welch SP
    Drug Alcohol Depend; 1997 Jan; 44(1):41-6. PubMed ID: 9031819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of a high level of morphine antinociceptive tolerance in mice involves both PKC and PKA.
    Smith FL; Javed RR; Elzey MJ; Dewey WL
    Brain Res; 2003 Sep; 985(1):78-88. PubMed ID: 12957370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
    Narita M; Mizoguchi H; Kampine JP; Tseng LF
    Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice.
    Smith FL; Javed RR; Smith PA; Dewey WL; Gabra BH
    Pharmacol Res; 2006 Dec; 54(6):474-80. PubMed ID: 17056270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKC and PKA inhibitors reverse tolerance to morphine-induced hypothermia and supraspinal analgesia in mice.
    Javed RR; Dewey WL; Smith PA; Smith FL
    Eur J Pharmacol; 2004 May; 492(2-3):149-57. PubMed ID: 15178359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C.
    Ohsawa M; Kamei J
    Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of several kinases in mice tolerant to delta 9-tetrahydrocannabinol.
    Lee MC; Smith FL; Stevens DL; Welch SP
    J Pharmacol Exp Ther; 2003 May; 305(2):593-9. PubMed ID: 12606657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice.
    Ohsawa M; Kamei J
    Eur J Pharmacol; 1999 May; 372(3):221-8. PubMed ID: 10395015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in brain Protein Kinase A activity and reversal of morphine tolerance by two fragments of native Protein Kinase A inhibitor peptide (PKI).
    Dalton GD; Smith FL; Smith PA; Dewey WL
    Neuropharmacology; 2005 Apr; 48(5):648-57. PubMed ID: 15814100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trifluoperazine, an orally available clinically used drug, disrupts opioid antinociceptive tolerance.
    Tang L; Shukla PK; Wang ZJ
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):1-4. PubMed ID: 16380209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the phosphatidylinositol-specific phospholipase C pathway in delta-opioid receptor-mediated antinociception in the mouse spinal cord.
    Narita M; Ohsawa M; Mizoguchi H; Aoki T; Suzuki T; Tseng LF
    Neuroscience; 2000; 99(2):327-31. PubMed ID: 10938438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of inwardly rectifying K+ channel in OK proximal tubule cells involves cGMP-dependent phosphorylation process.
    Kubokawa M; Nakaya S; Yoshioka Y; Nakamura K; Sato F; Mori Y; Kubota T
    Jpn J Physiol; 1998 Dec; 48(6):467-76. PubMed ID: 10021500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible mechanisms for insulin-induced attenuation of the antinociceptive effect of [D-Ala2, N-MePhe4, Gly-ol5]enkephalin.
    Ohsawa M; Tanaka S; Kamei J
    Eur J Pharmacol; 1999 Jun; 373(2-3):181-6. PubMed ID: 10414437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets.
    Libersan D; Rousseau G; Merhi Y
    Thromb Haemost; 2003 Feb; 89(2):310-7. PubMed ID: 12574812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of spinal protein kinase C in the suppression of morphine-induced rewarding effect under a neuropathic pain-like state in mice.
    Narita M; Oe K; Kato H; Shibasaki M; Narita M; Yajima Y; Yamazaki M; Suzuki T
    Neuroscience; 2004; 125(3):545-51. PubMed ID: 15099668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
    Haikala H; Kaheinen P; Levijoki J; Lindén IB
    Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and beta-endorphin-induced antinociception in the mouse.
    Xu JY; Tseng LF
    J Pharmacol Exp Ther; 1995 Jul; 274(1):8-16. PubMed ID: 7616452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protein phosphatases alters the expression of morphine tolerance in mice.
    Bernstein MA; Welch SP
    Eur J Pharmacol; 1998 Jan; 341(2-3):173-7. PubMed ID: 9543237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose morphine induces hyperalgesia through activation of G alphas, protein kinase C, and L-type Ca 2+ channels in rats.
    Esmaeili-Mahani S; Shimokawa N; Javan M; Maghsoudi N; Motamedi F; Koibuchi N; Ahmadiani A
    J Neurosci Res; 2008 Feb; 86(2):471-9. PubMed ID: 17893922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.